Home Biomarkers Pro-Myelocytes

Pro-Myelocytes

CBC Biomarker

Sample Needed

Collection Type: Blood

Body System

Related System: CBC

Overview

Pro‑myelocytes (promyelocytes) are an early stage in granulocyte development found normally in the bone marrow as immature precursors between myeloblasts and myelocytes. A CBC with peripheral blood smear can detect their presence in circulating blood; ordinarily they are absent from peripheral blood. Finding pro‑myelocytes in the bloodstream suggests a “left shift” (release of immature neutrophil precursors) and can point to severe infection, inflammation, marrow stress or failure, or hematologic malignancies (for example myeloproliferative disorders or acute leukemias). Symptoms prompting evaluation include fever, unexplained high or low white cell counts, recurrent or severe infections, bruising, fatigue, or unexplained systemic illness. Normal counts vary little by gender or adult age; neonates and infants may show more immature forms during stress.

People also test for

Test Preparation

No special preparation is required

Why Do I Need This Test

Included in: CBC with differential and peripheral blood smear review.
Symptoms indicating test: fever, sepsis-like illness, unexplained leukocytosis or leukopenia, bleeding, recurrent infections, fatigue, or marrow failure signs.
Conditions diagnosed/monitored: severe bacterial infection, systemic inflammation, bone marrow stimulation, myelodysplastic syndromes, myeloproliferative neoplasms, acute leukemias.
Reasons for abnormal levels: infection, inflammation, marrow recovery after chemotherapy, hematologic malignancy, toxin/drug effects, severe stress.
Biological meaning: circulating pro‑myelocytes indicate accelerated or disordered granulopoiesis and potential marrow pathology.
Behaviors/lifestyle: heavy smoking, corticosteroid use, recent severe illness or trauma can mobilize immature cells; alcohol and certain drugs can suppress marrow.
Family history: relatives with leukemia, myelodysplasia, or inherited marrow disorders increases suspicion.

Run our symptom checker to see if this test is right for you

Symptom Checker

Understanding Test Results

Any detection of pro‑myelocytes in peripheral blood is considered abnormal.
Interpretation by degree: Trace/rare (reported as occasional cells or <1%): mild left shift—often reactive to acute infection, inflammation, or recent marrow stimulation; correlate with clinical signs and neutrophil count.
1–5% (mild to moderate): more significant marrow response or early marrow involvement—seen with severe bacterial infections, systemic inflammation, or early marrow stress.
>5–10% (marked): suggests pronounced marrow disruption or malignant process; raises concern for myeloproliferative neoplasm, myelodysplasia, or evolving acute leukemia.
Very high percentages with increased blasts or abnormal promyelocyte morphology: strongly suggest acute leukemia (for example acute promyelocytic leukemia) and may require urgent hematology review because of complications such as coagulopathy.
Any abnormal result should prompt repeat testing, full CBC/differential, bone marrow evaluation when indicated, and correlation with clinical findings and other labs (CRP, cultures, peripheral smear morphology).

Normal Range

0% (absent in peripheral blood)

FAQs

Q: What do myelocytes in blood indicate?

A: Myelocytes are immature granulocytic white blood cells normally confined to bone marrow. Their appearance in peripheral blood (myelocytosis) indicates significant bone-marrow stress or abnormality commonly severe infection, inflammation, or recovery from marrow suppression. It can also suggest myeloproliferative disorders or leukemia. Detection warrants prompt clinical evaluation, further blood tests, and often bone-marrow examination to find the cause.

Q: What is a pro-myelocyte?

A: A pro-myelocyte is an early granulocytic precursor cell in the bone marrow, appearing after the myeloblast stage and before the myelocyte. It is larger than blasts, with a round-to-oval nucleus, visible nucleoli, abundant basophilic cytoplasm and prominent azurophilic (primary) granules. Pro-myelocytes proliferate and differentiate into mature granulocytes (neutrophils, eosinophils, basophils) during granulopoiesis.

Q: Is it normal to have promyelocytes in blood?

A: No promyelocytes are immature granulocyte precursors normally confined to bone marrow. Finding them in peripheral blood is not typical and suggests a “left shift” from severe infection, stress, marrow recovery, or a bone marrow disorder. A few may appear transiently, but persistent or numerous promyelocytes require prompt evaluation (repeat CBC, peripheral smear and possibly bone marrow testing) to exclude serious conditions such as acute promyelocytic leukemia.

Q: Should I be worried if my metamyelocytes are high?

A: Elevated metamyelocytes indicate increased immature neutrophils released from the bone marrow, often due to infection, inflammation, severe stress, or less commonly marrow disorders. It isn’t a diagnosis itself but requires further evaluation: repeat CBC, review symptoms and other white-cell changes, and possibly bone‑marrow tests. See your clinician promptly urgently if you have fever, worsening symptoms, or markedly abnormal blood counts.

Q: What do high eosinophils mean?

A: High eosinophils (eosinophilia) indicate an elevated type of white blood cell often seen with allergies (asthma, hay fever), parasitic infections, drug reactions, autoimmune diseases, certain cancers, or primary eosinophilic disorders. They reflect immune activation and can cause inflammation in lungs, skin, or gut. Clinical significance depends on the count and symptoms; doctors will usually repeat tests, investigate causes, and treat accordingly.

Q: What does increased promyelocyte mean?

A: Increased promyelocytes indicate a rise in immature white blood cell precursors. A few in blood can reflect marrow response to infection, inflammation, stress, or recovery after suppression; marked increases raise concern for acute myeloid leukemia (including acute promyelocytic leukemia) or other marrow disorders. Interpretation requires clinical context, repeat blood testing and further evaluation by a clinician (bone marrow exam and genetic/molecular tests may be needed).